ASPR Invests Millions to Strengthen Domestic Production of Critical Medicines Pharmaceutical Ingredients, Reducing Reliance on Foreign Resources +++

ASPR Invests Millions to Strengthen Domestic Production of Critical Medicines Pharmaceutical Ingredients, Reducing Reliance on Foreign Resources https://aspr.hhs.gov/newsroom/Pages/NewsRoomHome.aspx Save the Date! IBMSC Industry Summit 2026 Will Collect Industry Feedback to Inform Development of the First-ever HHS Industrial Base Policy Framework https://aspr.hhs.gov/IBMSC/IndustrySummit2026/Pages/default.aspx DATE AND TIME April 21, 2026 BARDA Launches $100 Million Prize Competition to Spur Innovation in Broad-spectrum,Small-molecule Antivirals Targeting Viruses in the Togaviridae and Flaviviridae Families https://aspr.hhs.gov/newsroom/Pages/SMART-Antiviral-Prize-Feb2026.aspx Today, the Biomedical Advanced Research and Development Authority (BARDA), within the Administration for Strategic Preparedness and Response (ASPR), in collaboration with VITAL – a BARDA Accelerator Network Hub – opened solicitations for the SMART Antiviral Prize, a $100M initiative supporting development of broad-spectrum, small-molecule antiviral therapies targeting viruses in the Togaviridae and Flaviviridae families.